PEDIATR EMERG CARE 润色咨询

PEDIATRIC EMERGENCY CARE

出版年份：1985 年文章数：3877 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2023-01-04 ms4000000785695188 来自广东省

    审稿速度:6.0
    经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 MS68862005

    引言和讨论如何写的不重复？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    和讨论比，引言撰写的方式有什么不同？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2021-12-21 ms2000000125490281

    12月9号投，12月20号reject，残忍😭

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    审稿时间有点长

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2017-07-14 zhengxiaobing

    跨过一分大关,神仙保佑!!明年超过2分吧

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2015-02-28 ethan411

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2108802, encodeId=20612108802b6, content=审稿速度:6.0<br>经验分享：审稿6个月没回复，给编辑写了信退稿，写两封信也没反应, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0c75577752, createdName=ms4000000785695188, createdTime=Wed Jan 04 16:51:06 CST 2023, time=2023-01-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1097133, encodeId=afb4109e13362, content=引言和讨论如何写的不重复？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1097134, encodeId=7432109e1342c, content=和讨论比，引言撰写的方式有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082505, encodeId=0bc7108250537, content=12月9号投，12月20号reject，残忍😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d865507314, createdName=ms2000000125490281, createdTime=Tue Dec 21 11:01:48 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578559, encodeId=fb825e8559e8, content=审稿时间有点长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541933, encodeId=2d02541933a5, content=跨过一分大关,神仙保佑!!明年超过2分吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhengxiaobing, createdTime=Fri Jul 14 18:47:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=510075, encodeId=b7135100e5e2, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：不得不说这是一个垃圾杂志，我忍了他很久了，一个过敏性休克的个案报道投稿链两个月后修回，接着就是漫长的等待，中间分别间隔3个月问一次，都说要等消息，结果一年后被拒，简直就是一个垃圾！见不不负责任的，但是没有见过这种，希望他能及早从SCI行列除名……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=395, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=685a92872, createdName=ethan411, createdTime=Sat Feb 28 09:22:00 CST 2015, time=2015-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481641, encodeId=213f4816413b, content=偏重的研究方向：儿科;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=PEDIA—doctor, createdTime=Wed Jun 29 16:55:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 PEDIA—doctor

    偏重的研究方向：儿科;

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分